301
Participants
Start Date
June 20, 2018
Primary Completion Date
December 3, 2019
Study Completion Date
June 16, 2020
DaxibotulinumtoxinA for injection
DaxibotulinumtoxinA for injection is a sterile, white to off-white lyophilized product containing the active ingredient, daxibotulinumtoxinA, and inactive ingredients to be reconstituted with sterile, non-preserved, 0.9% sodium chloride solution saline.
Placebo
Placebo is a sterile lyophilized product consisting of inactive ingredients without the neurotoxin to be reconstituted with sterile, non-preserved 0.9% sodium chloride solution.
Universitaetsklinik fuer Neurologie, Vienna
Medical University Innsbruck, Innsbruck
Mount Sinai Movement Disorders Center, New York
Praxis fuer Neurologie im Bismark Karrée, Berlin
Neurologicka klinika 1. LF UK a VFN v Praze, Prague
University of Rochester, Rochester
Thomas Jefferson University, Philadelphia
University of Pennsylvania, Department of Neurology, Philadelphia
MedStar Georgetown University Hospital, Washington D.C.
Wake Forest Health Sciences, Winston-Salem
Duke University, Durham
Hospital Universitario de La Princesa, Madrid
Medical University of South Carolina, Charleston
Coastal Neurology, Port Royal
CHU Caremeau, Service de Neurologie, Nîmes
Emory University, Atlanta
Marta Dagmara BANACH Marta Banach Specjalistyczny Gabinet Neurologiczny, Krakow
Medizinische Hochschule Hannover, Hanover
Krakowska Akademia Neurologii, Krakow
University of Florida Health Science Center Jacksonville, Jacksonville
University of Florida Center for Movement Disorders and Neurorestoration, Gainesville
Infinity Clinical Research, Hollywood
University of Miami, Miami
Design Neuroscience Center, Doral
Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton
USF Parkinson's Disease and Movement Disorders Center, Tampa
Vanderbilt University Medical Center, Nashville
Texas Neurology. P.A., Dallas
Wesley Neurology Clinic, Cordova
CHU Grenoble Alpes, Grenoble
Universitaetsklinikum Duesseldorf, Düsseldorf
Henry Ford West Bloomfield Hospital, West Bloomfield
QUEST Research Institute, Farmington
Michigan State University, East Lansing
Vestra Clinics s.r.o., Rychnov nad Kněžnou
Lekarna Pardubicke nemocnice, Pardubice
GFO Kliniken Troisdorf, Betriebsstätte St. Johannes Sieglar, Troisdorf
Hôpital Roger Salengro - CHRU de Lille, Lille
Rush University Medical Center, Chicago
St Louis University, St Louis
Washington University, St Louis
University of Nebraska Medical Center, Omaha
Hôpital Neurologique Pierre Wertheimer, Bron
Fakultní nemocnice Ostrava, Neurologicka klinika, Ostrava-Poruba
Universitätsklinikum Tübingen, Tübingen
Baylor College of Medicine, Houston
Houston Methodist Neurological Institute, Houston
Central Texas Neurology Consultants, Round Rock
Rocky Mountain Movement Disorders Center, Englewood
Szpital sw. Wojciecha Podmiot Leczniczy Copernicus Sp. Z o.o., Gdansk
Klinikum rechts der Isar der TUM, München
HOPE Research Institute, Phoenix
USC Keck School of Medicine, Los Angeles
Care Access Research, Pasadena
Loma Linda University, Loma Linda
University of California, Irvine, Irvine
The Parkinsons and Movement Disorder Institute, Fountain Valley
Sutter Institute for Medical Research, Sacramento
Movement Disorders Center of Arizona, Scottsdale
Associated Neurologist, P.C., Danbury
New England Institute for Clinical Research, Stamford
Suncoast Neuroscience Associates, St. Petersburg
Kansas Institute of Reseach, Overland Park
University of Vermont Medical Center, Burlington
University Health Network, Toronto Western Hospital, Toronto
Fakultni nemocnice Olomouc, Neurologicka klinika, Olomouc
Wojewodzki Szpital Specjalistyczny w Olsztynie, Olsztyn
Centrum Medyczne Pratia Warszawa, Warsaw
Mazowiecki Szpital Brodnowski Sp. z o.o., Warsaw
Hospital Universitari Vall d'Hebron, Barcelona
Hospital de la Santa Creu i Sant Pau, Barcelona
Hospital Universitario Burgos, Burgos
Royal Devon and Exeter Foundation Trust Hospital, Exeter
The Walton Centre NHS Foundation Trust, Liverpool
Salford Royal NHS Foundation Trust, Salford
Collaborators (1)
Syneos Health
OTHER
Revance Therapeutics, Inc.
INDUSTRY